United States · FDA National Drug Code directory
ZIMHI
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 84571-140_4525b96b-5ab9-b8fd-e063-6294a90aa699
- Product NDC
- 84571-140
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Naloxone Hydrochloride
- Labeler
- ZMI Pharma Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220115
- Source listing expiry
- 20261231
Source-listed ingredients
- NALOXONE HYDROCHLORIDE — 5 mg/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 CASE in 1 CARTON (84571-140-02) / 1 SYRINGE in 1 CASE / .5 mL in 1 SYRINGE · 84571-140-02
- 1 CASE in 1 CARTON (84571-140-11) / 1 SYRINGE in 1 CASE / .5 mL in 1 SYRINGE · 84571-140-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →